BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 32630630)

  • 1. Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy.
    Urbizu A; Beyer K
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation in the pathophysiology of Lewy body dementia.
    Chouliaras L; Kumar GS; Thomas AJ; Lunnon K; Chinnery PF; O'Brien JT
    Prog Neurobiol; 2020 Sep; 192():101822. PubMed ID: 32407744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
    Walker L; Stefanis L; Attems J
    J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease.
    Marsal-García L; Urbizu A; Arnaldo L; Campdelacreu J; Vilas D; Ispierto L; Gascón-Bayarri J; Reñé R; Álvarez R; Beyer K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Overlap of Pathologies in Lewy Body Disorders.
    Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating distinct molecular signatures of Lewy body dementias.
    Harvey J; Pishva E; Chouliaras L; Lunnon K
    Neurobiol Dis; 2023 Nov; 188():106337. PubMed ID: 37918758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of genetic association studies in people with Lewy body dementia.
    Sanghvi H; Singh R; Morrin H; Rajkumar AP
    Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of dementia with Lewy bodies: what are we missing?
    Meeus B; Theuns J; Van Broeckhoven C
    Arch Neurol; 2012 Sep; 69(9):1113-8. PubMed ID: 22635379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and neuropathological characteristics of dementia with Lewy bodies].
    Bencze J; Simon V; Bereczki E; Majer R; Varkoly G; Murnyák B; Kálmán J; Hortobágyi T
    Orv Hetil; 2017 Apr; 158(17):643-652. PubMed ID: 28434243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges.
    Combi R; Salsone M; Villa C; Ferini-Strambi L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Clinical, neuropathological and genetic features of Lewy body dementias.
    Hansen D; Ling H; Lashley T; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):635-654. PubMed ID: 30977926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology.
    Pihlstrøm L; Shireby G; Geut H; Henriksen SP; Rozemuller AJM; Tunold JA; Hannon E; Francis P; Thomas AJ; Love S; Mill J; van de Berg WDJ; Toft M
    Nat Commun; 2022 Aug; 13(1):4932. PubMed ID: 35995800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging for Lewy body disease: is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
    Vernon AC; Ballard C; Modo M
    Brain Res Rev; 2010 Oct; 65(1):28-55. PubMed ID: 20685363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease.
    Lockhart PJ; Kachergus J; Lincoln S; Hulihan M; Bisceglio G; Thomas N; Dickson D; Farrer MJ
    J Mol Neurosci; 2004; 24(3):337-42. PubMed ID: 15655258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.